科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1619Please respect copyright.ＰＥＮＡＮＡ3T1iDFqDjt
1619Please respect copyright.ＰＥＮＡＮＡglLD2slkli
上集：https://www.penana.com/article/4711251619Please respect copyright.ＰＥＮＡＮＡExtrNFkYcG
1619Please respect copyright.ＰＥＮＡＮＡtp4BvD4dHn
1619Please respect copyright.ＰＥＮＡＮＡD4VheOPJbt
1619Please respect copyright.ＰＥＮＡＮＡHYj8qWVWE3
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1619Please respect copyright.ＰＥＮＡＮＡZSvnKfmxVF
1619Please respect copyright.ＰＥＮＡＮＡgwIGN2wDLx
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1619Please respect copyright.ＰＥＮＡＮＡkIlKkK0EaB
1619Please respect copyright.ＰＥＮＡＮＡ7puNSD2pg3
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1619Please respect copyright.ＰＥＮＡＮＡ8aJD8Bt2BK
1619Please respect copyright.ＰＥＮＡＮＡ1gF0BgT4WO
1619Please respect copyright.ＰＥＮＡＮＡeX4TjvXeUG
1619Please respect copyright.ＰＥＮＡＮＡImDOpvbKiw
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1619Please respect copyright.ＰＥＮＡＮＡGiEjsVp22P
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1619Please respect copyright.ＰＥＮＡＮＡHI7Upw5lv1
1619Please respect copyright.ＰＥＮＡＮＡ3ffodF4sFe
忘記甚麼是Neoantigen的話，可重溫上一集。1619Please respect copyright.ＰＥＮＡＮＡnbjAjl4Bz7
1619Please respect copyright.ＰＥＮＡＮＡ1xfRxcjFMp
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1619Please respect copyright.ＰＥＮＡＮＡDzUu6eSGca
1619Please respect copyright.ＰＥＮＡＮＡ7XzcbflCw8
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1619Please respect copyright.ＰＥＮＡＮＡ4juqg2jUuV
1619Please respect copyright.ＰＥＮＡＮＡtqbiyhl2Pm
1619Please respect copyright.ＰＥＮＡＮＡMjcBYVw6ln
1619Please respect copyright.ＰＥＮＡＮＡvlF6pBacie
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1619Please respect copyright.ＰＥＮＡＮＡlxuskSSmPf
1619Please respect copyright.ＰＥＮＡＮＡrct5skN402
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1619Please respect copyright.ＰＥＮＡＮＡY24nbyb6cz
1619Please respect copyright.ＰＥＮＡＮＡeg7f0tdISX
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1619Please respect copyright.ＰＥＮＡＮＡGlvGbgNJ6q
1619Please respect copyright.ＰＥＮＡＮＡbN31eQnlVy
1619Please respect copyright.ＰＥＮＡＮＡDgwtWmwJoe
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1619Please respect copyright.ＰＥＮＡＮＡjYBYKGvBb5
1619Please respect copyright.ＰＥＮＡＮＡbbST0piicO
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1619Please respect copyright.ＰＥＮＡＮＡNjBZR6Duu6
1619Please respect copyright.ＰＥＮＡＮＡrtpkujmimk
1619Please respect copyright.ＰＥＮＡＮＡlrJmAeMCOk
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1619Please respect copyright.ＰＥＮＡＮＡ9SZUEHrslo
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1619Please respect copyright.ＰＥＮＡＮＡytrUGrLDJg
1619Please respect copyright.ＰＥＮＡＮＡhVFqTFaOZk
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1619Please respect copyright.ＰＥＮＡＮＡpk8i6Laib7
1619Please respect copyright.ＰＥＮＡＮＡTWfGHv5MK2
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1619Please respect copyright.ＰＥＮＡＮＡP6eASnTJ8N
1619Please respect copyright.ＰＥＮＡＮＡaTXTbe0QXg
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1619Please respect copyright.ＰＥＮＡＮＡNylXJA1jBl
1619Please respect copyright.ＰＥＮＡＮＡlO9iQ8k39U
1619Please respect copyright.ＰＥＮＡＮＡUtDEUxDqZj
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1619Please respect copyright.ＰＥＮＡＮＡ9anXfanDfb
1619Please respect copyright.ＰＥＮＡＮＡZ1BDcFhZXG
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1619Please respect copyright.ＰＥＮＡＮＡGhE32dTTv8
1619Please respect copyright.ＰＥＮＡＮＡjIQUP5kNQv
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1619Please respect copyright.ＰＥＮＡＮＡdB8BBXht2M
1619Please respect copyright.ＰＥＮＡＮＡv67pIWFf8w
Link:1619Please respect copyright.ＰＥＮＡＮＡubqs7v1Ipq
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1619Please respect copyright.ＰＥＮＡＮＡOgzI1lBRx1
1619Please respect copyright.ＰＥＮＡＮＡxq7dmXjdo8
1619Please respect copyright.ＰＥＮＡＮＡ2WomWF9RZn
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1619Please respect copyright.ＰＥＮＡＮＡEb2XEI0zfD